SciClone Pharmaceuticals Competitors and Similar CompaniesClear all

SciClone Pharmaceuticals's competitors and similar companies include EyePoint Pharmaceuticals.
SciClone Pharmaceuticals
SciClone Pharmaceuticals
SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
Founding Date
Founding Date
1989
Founding Date
1987
Type
Type
Private
Type
Public
Tags
Locations
Locations
Foster City, US HQ
Locations
Watertown, US HQ
Employees
Employees
1102% decrease
Employees
8453% increase

Financial

Revenue (est.)
Revenue (est.)
$160.1m (FY, 2016)
Revenue (est.)
$31.4m (FY, 2025)
Net income
Net income
$30.7m (FY, 2016)
Net income
($232m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

EyePoint Pharmaceuticals
HQ
Watertown, US
Employees
84

EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.

View company